Monogenic Diabetes Misdiagnosed as Type 1

Launched by MCGILL UNIVERSITY HEALTH CENTRE/RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE · Jun 14, 2019

Keywords

ClinConnect Summary

This clinical trial is looking at a specific type of diabetes known as monogenic diabetes, which can sometimes be mistaken for type 1 diabetes (T1D). The study has two main goals: first, to find out how often monogenic diabetes is misdiagnosed as T1D and to create a method to help identify these cases. Second, researchers want to discover new genes that may cause monogenic diabetes that has been misclassified as T1D. This is important because understanding the correct type of diabetes can lead to better treatment options for patients.

If you're considering participating in this trial, you could be eligible if you were diagnosed with diabetes before the age of 25, either as type 1 or if your diagnosis was unclear. However, if you have already tested positive for specific autoantibodies related to T1D, you would not be able to join. Participants will undergo assessments to help identify the type of diabetes they have, and this could contribute to important findings in diabetes research. The trial is currently recruiting participants of all genders, and ages can range from as young as 1 year to over 91 years.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of diabetes under the age of 25 as either type 1 or undetermined type.
• Exclusion Criteria:
• • Existing T1D autoantibody testing with a positive result